Capital Income Builder Cl C Shares (CIBCX)
CIBCX is a mutual fund that focuses on generating income and building capital for its investors. It is classified as a Class C share, meaning it has a lower initial investment requirement and may have higher ongoing fees compared to other share classes. The fund invests in a diverse portfolio of assets, including stocks, bonds, and other securities, with the goal of providing a steady stream of income and long-term growth potential. CIBCX is suitable for investors looking for a balanced approach to income and capital growth.
CIBCX Mutual Fund Chart & Stats
- Previous Close
- $84.75
- Sub-Category
- Asset Allocation
- Total Liabilities
- $2.85B
- Expense Ratio
- 1.33%
- Holding Count
- 2,766
- Brand
- Capital Income Builder
- Category
- Balanced
- Total Assets
- 133.31B
- Shares Outstanding
- N/A
- 52-Week Range
- $76.54 - $85.41
CIBCX Mutual Fund News
AstraZeneca Builds Hong Kong Breast Cancer Evidence in New Real-World Study
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s official study title is Breast Cancer Real-World Insights and Decision Guidance Evaluation (BRIDGE-HK) An Observational, Retrospective,
Top 10 Holdings
| Name | Weight % |
|---|---|
| USD_CASHCAPITAL GROUP CENTRAL CASH FUND | 4.22% |
| AVGOBroadcom Inc. | 4.02% |
| 2330TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | 3.38% |
| PMPhilip Morris International | 2.94% |
| CCBFXCAPITAL GROUP CENTRAL CORPORATE BOND FUND | 2.04% |
| ABBVAbbvie | 1.93% |
| BATSBritish American Tobacco (UK) | 1.85% |
| RTXRtx Corporation | 1.57% |
| JPMJPMorgan Chase & Co. | 1.17% |
| AZNAstraZeneca plc | 1.10% |
| Total | 24.21% |
Recently Viewed
No data currently available














